Search results for "" 2269 results found
Sort By
By Date
By Relevance
-
IP Cases & Articles
Domain names: No roving on Jaguars cyber land
Famous worldwide as a manufacturer of premium vehicles, Jaguar Land Rover Limited (the complainant) owns numerous trade marks, including Australian national trade marks, for JAGUAR, LAND ROVER and RANGE ROVER. -
News
Hanns-Juergen Grosse joins our Munich team
Hanns-Juergen Grosse joins D Young & Co LLP’s patent electronics, engineering & IT practice. -
Newsletter
Trade Mark Newsletter No.90
-
IP Cases & Articles
Patentability of products of biological processes
In our December patent newsletter [see note 1 below] we reported the publication of a notice from the European Commission on its interpretation of certain aspects of the so-called 'Biotech Directive' (Directive 98/44/EC). A conclusion of the notice was inter alia that under Article 4 of the Biotech Directive, there… -
News
EPO Board of Appeal Decisions book is published
As part of D Young & Co celebrating 125 years in business, it is with great pleasure that we present this first edition of a synopsis of decisions from the EPO Boards of Appeal. -
IP Cases & Articles
Raytheon: On-demand instantiation in a computing system
On the 22 June 2016 the Technical Board of Appeal issued its decision (T 1742/12) regarding an appeal concerning the selection of closest prior art when it is ambiguous as to which document is closest to the claimed arrangement. -
IP Cases & Articles
Patent litigation: expedited cases and numerical limits
In our October 2016 newsletter we commented on patent litigation in the UK in the light of Brexit. As we noted there, UK patent litigation proceedings have a strong reputation for quality, which will endure, and real efforts are being made to improve costs and efficiency. -
IP Cases & Articles
Undisclosed disclaimers - Enlarged Board of Appeal
New questions have been referred to the EPO Enlarged Board of Appeal regarding the allowability of disclaimers. -
IP Cases & Articles
Hospira v Genentech - Herceptin formulation obvious
In July this year, the Court of Appeal handed down a decision in Hospira v Genentech [2016] EWCA Civ 780 which upheld the decision by Birss J in November 2014 to revoke the two Herceptin formulation patents for obviousness and added matter. -
IP Cases & Articles
Warner Lambert v Actavis: Swiss form claims
The Court of Appeal has decided the latest instalment of the pregabalin second medical use litigation between Warner-Lambert (part of Pfizer) and Actavis (and other generics manufacturers) in the UK.
Page 163 of 227
Previous Next